Oncology

Boston-based Dana-Farber Cancer Institute and Brigham and Women's Hospital were designated as a Pheo Para Clinical Center June 28 for patients with rare neuroendocrine tumors.

St. Louis-based Washington University School of Medicine received a $5.3 million grant June 28 from the National Cancer Institute of the National Institutes of Health for lung cancer recurrence research efforts. 

Here are four moves from leading cancer centers across the nation that Becker's has covered since June 8: 

Alex Adjei MD, PhD, will serve as the new chair of Cleveland Clinic's Taussig Cancer Institute starting in July, the system said June 23.

Nashville, Tenn.-based HCA Healthcare inked a deal with McKesson June 23 to enter a joint venture combining the two institutions' cancer research efforts.

The University of Texas MD Anderson Cancer Center, Invectys and the Cell Therapy Manufacturing Center entered a strategic collaboration last week to develop a "reliable, compliant and scalable" process for human leukocyte antigen CAR-T cell therapy for solid tumors. 

Cleveland Clinic Mercy Hospital is in the early stages of developing a $10.3 million cancer center, The Repository reported June 20.

Scottsdale, Ariz.-based HonorHealth researchers developed a novel drug combination therapy for pancreatic cancer patients that has become part of the new National Comprehensive Cancer Network guidelines for the disease, the system shared with Becker's.

Six hospitals and health systems that have opened specialty cancer facilities or shared plans to open new centers since April: 

Fargo, N.D.-based Sanford Roger Maris Cancer Center launched its new bone marrow transplant program June 14, KFGO reported.